FDA Inspection
Summa Health SystemSumma Health System – FDA Inspection, Mar 21, 2023
Record Details
This FDA Inspection record concerns Summa Health System, with an inspection on March 21, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 67e5e470-47a6-4280-9176-66734b153418
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1200440
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Summa Health System
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2025 | Not classified | Cincinnati District Office | |
| February 14, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 27, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 24, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 23, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Summa Health System
- FDA Inspection 1261356 - 2025-02-11
- FDA Inspection 1079942 - 2019-02-14
- FDA Inspection 998458 - 2017-01-27
- FDA Inspection 919237 - 2015-03-24
- FDA Inspection 815176 - 2013-01-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.